PS32: CAN RESILIENCE IMPROVE OUTCOMES FOR PATIENTS IN ACUTE PSYCHOSIS? A PILOT STUDY

Lobby

AUTHORS
Antanas Kiziela1, Rima Viliūnienė2

1Vilnius University Medical Faculty, Vilnius, Lithuania
2Vilnius University Medical Faculty Psychiatric Clinic, Vilnius, Lithuania

 

ABSTRACT DESCRIPTION

Background: Higher level of resilience has shown to predict better outcomes for healthy subjects after distress and patients with chronical mental problems after treatment, however it is unclear whether patients in acute psychosis could benefit from higher resilience. In this study we used resilience scale for adults (RSA) to evaluate the impact of resilience on psychiatric symptoms measured by brief psychiatric rating scale (BPRS).

Objectives: To examine if resilience increases significantly during the treatment. To measure if patients with higher resilience have better outcomes (less psychiatric symptoms).

Method: A longitudinal quantitative study was conducted in women acute psychosis unit in Vilnius city mental health center. 18 patients (17 diagnosed with schizophrenia and 1 schizoaffective disorder) were enrolled. Subjects were rated on BPRS and asked to complete RSA questionnaire two times: 1) during the first 3 days of treatment; 2) one month from admission or before leaving the unit if discharged earlier, but no less than 2 weeks. Participation was voluntary.

Results: Resilience score has increased significantly during the treatment (4.3 vs. 4.8; p < 0.001). At the beginning of the treatment resilience and BPRS results correlated significantly with negative medium strength (p < 0.05, r = -0.518). There were no significant differences in change of BPRS score between group with high RSA scores and group with lower RSA scores.

Conclusions: Treatment in acute psychosis unit significantly increased patient’s resilience even after first 2 – 4 weeks. The patients with higher resilience scored less on BPRS and thus it may suggest that resilience could help to cope with psychosis symptoms. However, the relief of psychiatric symptoms during the treatment was not affected by resilience.

Poster Session